As anticipated, administration of cholestyramine significantly reduced the serum levels of total bile acids and plasma LPS levels in KC mice, which was further related to attenuation of systemic TNF-alpha levels in vivo (Figure 2D and Figure S2B,C). This evidence concerns the gene TNF and keratoconus.